Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Rigel Pharmaceuticals, Inc.”

373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 373
Index total 30,257
Page 8 / 16

Quick answer

This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

373 results for “Rigel Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9040527

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  2. US 9034881

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted
  3. US 9018204

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted
  4. US 8993585

    Cyclic amine substituted pyrimidinediamines as PKC inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  5. US 8987303

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted
  6. US 8980921

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted
  7. US 8962643

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  8. US 8951504

    (trimethoxyphenylamino) pyrimidinyl formulations

    Rigel Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  9. US 8933080

    Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  10. US 8927564

    Synthesis of polycyclic alkaloids

    Rigel Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted
  11. US 8912170

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  12. US 8906922

    Substituted triazoles useful as AXl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  13. US 8895578

    Carboxamide, sulfonamide and amine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  14. US 8853397

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  15. US 8846908

    Tricyclic carbamate JAK inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  16. US 8846600

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  17. US 8835430

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  18. US 8822685

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  19. US 8815848

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  20. US 8809370

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  21. US 8809341

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  22. US 8809347

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  23. US 8809364

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  24. US 8796254

    Methods for using carboxamide, sulfonamide and amine compounds

    Rigel Pharmaceuticals, Inc. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted